New data for emapalumab in the treatment of macrophage activation syndrome to be presented at the ACR conference ...Middle East

PR Newswire - News
New data for emapalumab in the treatment of macrophage activation syndrome to be presented at the ACR conference
STOCKHOLM, Oct. 30, 2024 /PRNewswire/ -- Sobi® (STO: SOBI) today announced that new research showing the effect of emapalumab in patients with macrophage activation syndrome (MAS) in Still's disease, including systemic juvenile idiopathic arthritis (sJIA) and adult-onset still's disease...

Hence then, the article about new data for emapalumab in the treatment of macrophage activation syndrome to be presented at the acr conference was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( New data for emapalumab in the treatment of macrophage activation syndrome to be presented at the ACR conference )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News